Opportunity Oxford Wind Turbines (OWT) patented technology is a disruptive wind turbine design which is smartly made from mass produced, standard and mature components, with increased efficiency and reduced cost, as well as addit...
Oxford University Innovation constantly seeks investors for its new technology companies and organises its investor network through the Oxford Angels Network (OAN).
Invest in new technology companies
If you are looking to invest in new technology companies, you can find all our technology investment opportunities below:
No investor has acquired any first rights to invest in new Oxford University spinout companies, and Oxford University Innovation seeks investments into its spinouts from all investors.
Oxford’s spinout scene is vibrant, with between 15 to 20 university spinout opportunities being actively managed at any time in the pipeline.
Technology licensing to spinouts
Oxford University Innovation offers a standardised approach for licensing IP to new spinout companies on their formation, designed to support the thriving spinout ecosystem with simple licence terms and streamlined process. It ensures that financial returns to the inventors and University align directly with the returns to investors and commercial success of the companies formed, while giving maximum opportunity for the companies to thrive.
This approach is intended to boost both the volume and value of translated science from Oxford.
The licence for new spinouts has a structure that defers the majority of payments until an exit event or products reach the market, and includes:
- a fixed completion fee plus repayment of past patent costs
- a cash payment upon sale or exit of the venture
- no milestone or minimum sum payments
- no royalties on net sales are payable until a set threshold of sales has been reached
This licence is available only to spinouts intending to raise investment and only with standard legal terms, intended to speed up completion of the first round of investment and simplify processes post-completion. The document template can be downloaded here: OUI Spinout Express Licence (pdf, 724KB).
Oxford University Innovation’s previous practice was to structure a licence bespoke for each spinout company. These licences were mostly royalty based with milestones and minimum periodic payments. Should the spinout opt not to use the above standardised approach, Oxford University Innovation remains able to work with them to construct bespoke licence terms.
Background Multiple myeloma is a devastating incurable disease effecting around 10,000 patients in the UK at any one time. In these patients, myeloma cells are found near bone and in the bone marrow and so it typically affects mu...